CyPath Lung

Curated by Signal

Provider of a non-invasive lung cancer detection test

Overview

Provider of a non-invasive lung cancer detection test. It offers a test kit which allow patient to collect the sputum and send for diagnosis using AI-based flow cytometry data anlysis.

Key facts

Founded: 2022
Headquarters: San Antonio, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view
Commercial model: Sign up to view

Contact

Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Global Instrumentation
Developer of ECG recorder and analysis system
Life Sciences TechnologyManlius, United States
Active Motif
Provider of research kits, assays and biocomputing systems
Life Sciences TechnologyCarlsbad, United States
OmiCure
Provider of diagnostic solutions for cancer patients
Life Sciences TechnologyCambridge, United States

About CyPath Lung

What does CyPath Lung do?

Provider of a non-invasive lung cancer detection test.

Where is CyPath Lung headquartered?

CyPath Lung is headquartered in San Antonio, United States.

When was CyPath Lung founded?

CyPath Lung was founded in 2022.

Which sector is CyPath Lung in?

CyPath Lung operates in Life Sciences Technology.

Who are CyPath Lung's competitors?

Companies similar to CyPath Lung include Global Instrumentation, Active Motif, and OmiCure.